¿¬±¸µ¿ÇâÁ¤º¸
   
±Û¼ö : 658  
¹øÈ£ Á¦¸ñ ±Û¾´ÀÌ ÀÛ¼ºÀÏ Á¶È¸
438 ¸ð´õ³ª¹é½ÅÈ¿°ú, ¾ÈÀü¼º, ºÎÀÛ¿ë, µ¨Å¸º¯ÀÌ ¿¹¹æÈ¿°ú (Moderna COVID-19 Vaccine Over...°ü¸®ÀÚ2021.07.133802
437 µ¨Å¸º¯ÀÌ(B.1.617.2) ÁÖ¿ä Áõ»ó ¹× ±Û·Î¹ú È®»êÇöȲ°ü¸®ÀÚ2021.07.082675
436 [7/7] WHO ±Û·Î¹ú COVID-19 ¿ªÇÐ µ¿Çâ (COVID-19 Global Epidemiological Update )°ü¸®ÀÚ2021.07.072347
435 ¾Æ½ºÆ®¶óÁ¦³×Ä« & È­ÀÌÀÚ È¥ÇÕÁ¢Á¾ È¿°ú: Äڷγª19 ¹é½Å ±³Â÷Á¢Á¾È¿°ú¿Í ºÎ½ºÅ͹é½Å(M...°ü¸®ÀÚ2021.06.303161
434 ¡°µ¨Å¸ Ç÷¯½º(Delta Plus)¡± º¯ÀÌ ¹ÙÀÌ·¯½º Á¤º¸ ¹× ¹é½Å Á¢Á¾È¿°ú°ü¸®ÀÚ2021.06.2419497
433 ÃֽŠÀÇ°úÇÐ ¿¬±¸µ¿Çâ Å°¿öµå ºÐ¼®: 5¿ù ÀÇ°úÇкоߺ° ¿¬±¸µ¿Çâ ³×Æ®¿öÅ©°ü¸®ÀÚ2021.06.181144
432 [NEJM ÃֽŠ¿¬±¸] ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀÌµå µ¦»ç¸ÞŸ¼Õ ¼ö¼ú ÈÄ °¨¿°À§Çè°ü¸®ÀÚ2021.06.091663
431 [NEJM ÃֽŠ¿¬±¸] û¼Ò³â 12-15¼¼ ´ë»ó È­ÀÌÀÚ-¹ÙÀÌ¿À¿£ÅØ ¹é½Å(BNT162b2) 100% ¸é¿ª...°ü¸®ÀÚ2021.06.041622
430 COVID-19 ÆÒµ¥¹Í ÀÀ±Þ»óȲ¿¡¼­ ÀÏÇÏ°í ÀÖ´Â º¸°ÇÀÇ·áÀεéÀÇ Á¤½Å°Ç°­¹®Á¦°ü¸®ÀÚ2021.05.271830
429 AZ & È­ÀÌÀÚ ¹é½Å ±³Â÷Á¢Á¾ ºÎÀÛ¿ë Á¶±Ý ´õ ½ÉÇÏÁö¸¸ ±â°£Àº ±æÁö ¾ÊÀ½ °ü¸®ÀÚ2021.05.141910
428 Äڷγª19 ¹é½Å Á¾·ù¿¡ µû¸¥ ºÎÀÛ¿ë ºñ±³°ü¸®ÀÚ2021.05.148715
427 ÃֽŠ¿¬±¸°á°ú : Pfizer–BioNTech ¹é½Å- º¯À̹ÙÀÌ·¯½º(B.1.351) °¨¿° 75% º¸È£...°ü¸®ÀÚ2021.05.111565
426 ÃֽŠÀÇ°úÇÐ ¿¬±¸µ¿Çâ Å°¿öµå : 4¿ù ÀÇ°úÇкоߺ° ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© Å°¿öµåºÐ¼®°ü¸®ÀÚ2021.05.112256
425 Äڷγª19 º¯À̹ÙÀÌ·¯½º Á¤º¸ -SARS-CoV-2 Variants of Concern-°ü¸®ÀÚ2021.04.227050
424 [4/21] NIH ÃֽŠ¾÷µ¥ÀÌÆ® COVID-19 Ä¡·áÁöħ ¿ä¾à - Last Updated: April 21, 2021-°ü¸®ÀÚ2021.04.221987
423 COVID-19 ¹é½Å4°¡Áö À¯Çü ºñ±³°ü¸®ÀÚ2021.04.1983185
422 CDC & FDA: Á¸½¼ ¾Ø Á¸½¼(Johnson & Johnson), ¾á¼¾(Janssen) COVID-19 ¹é½ÅÁ¢Á¾ Áß...°ü¸®ÀÚ2021.04.152081
421 ÃֽŠÀÇ°úÇÐ ¿¬±¸µ¿Çâ Å°¿öµå ºÐ¼® : 3¿ù ÀÇ°úÇкоߺ° ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© Å°¿öµåºÐ¼®°ü¸®ÀÚ2021.04.141128
420 [4/9] WHO ±Û·Î¹ú COVID-19 ¿ªÇÐ µ¿Çâ (COVID-19 Global Epidemiological Update )°ü¸®ÀÚ2021.04.091816
419 ÃֽŠÀÓ»ó°á°ú(Phase III, Clinical Trial) ¿Á½ºÆ÷µå-¾Æ½ºÆ®¶óÁ¦³×Ä« ¹é½Å 76% È¿°ú°ü¸®ÀÚ2021.03.301916
  11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20